2023 Q2 Form 10-Q Financial Statement

#000095017023017333 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $264.6M $254.7M
YoY Change 0.93% 3.37%
Cost Of Revenue $197.6M $213.1M
YoY Change 1.17% 3.45%
Gross Profit $67.05M $41.54M
YoY Change 0.24% 2.95%
Gross Profit Margin 25.34% 16.31%
Selling, General & Admin $43.81M $41.23M
YoY Change 3.63% 2.64%
% of Gross Profit 65.34% 99.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.729M $1.677M
YoY Change 13.53% 11.21%
% of Gross Profit 2.58% 4.04%
Operating Expenses $45.54M $41.23M
YoY Change 7.72% -1.07%
Operating Profit $21.51M -$1.359M
YoY Change -6.85% 2.95%
Interest Expense $2.129M $38.00K
YoY Change 6351.52% -97.63%
% of Operating Profit 9.9%
Other Income/Expense, Net $19.00K $2.313M
YoY Change -98.78% 7128.13%
Pretax Income $23.66M $954.0K
YoY Change -4.01% 201.9%
Income Tax $6.641M $135.0K
% Of Pretax Income 28.07% 14.15%
Net Earnings $17.02M $819.0K
YoY Change -5.54% 184.38%
Net Earnings / Revenue 6.43% 0.32%
Basic Earnings Per Share $2.52 $0.12
Diluted Earnings Per Share $2.48 $0.12
COMMON SHARES
Basic Shares Outstanding 6.806M 6.876M
Diluted Shares Outstanding 6.875M 6.985M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $133.0M $132.7M
YoY Change 19.39% -68.06%
Cash & Equivalents $48.35M $52.64M
Short-Term Investments $84.66M $80.09M
Other Short-Term Assets $86.60M $128.8M
YoY Change -34.53% -2.94%
Inventory
Prepaid Expenses
Receivables $198.1M $188.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $417.7M $449.5M
YoY Change -18.19% -12.95%
LONG-TERM ASSETS
Property, Plant & Equipment $68.17M $47.27M
YoY Change 63.38% -21.16%
Goodwill $47.82M $47.82M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $138.3M $3.358M
YoY Change 5570.92% -97.91%
Total Long-Term Assets $254.2M $226.9M
YoY Change 3.46% -15.39%
TOTAL ASSETS
Total Short-Term Assets $417.7M $449.5M
Total Long-Term Assets $254.2M $226.9M
Total Assets $671.9M $676.4M
YoY Change -11.16% -13.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.701M $5.384M
YoY Change 31.94% 24.28%
Accrued Expenses $324.0M $330.5M
YoY Change -14.17% -13.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $335.8M $338.4M
YoY Change -13.84% -13.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $158.1M $164.5M
YoY Change -17.65% -20.48%
Total Long-Term Liabilities $158.1M $164.5M
YoY Change -17.65% -20.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $335.8M $338.4M
Total Long-Term Liabilities $158.1M $164.5M
Total Liabilities $493.9M $502.9M
YoY Change -15.1% -16.01%
SHAREHOLDERS EQUITY
Retained Earnings $169.3M $163.8M
YoY Change 2.36%
Common Stock $34.64M $33.63M
YoY Change 11.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $178.0M $173.5M
YoY Change
Total Liabilities & Shareholders Equity $671.9M $676.4M
YoY Change -11.16% -13.78%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $17.02M $819.0K
YoY Change -5.54% 184.38%
Depreciation, Depletion And Amortization $1.729M $1.677M
YoY Change 13.53% 11.21%
Cash From Operating Activities $3.318M -$26.52M
YoY Change -146.04% -12.23%
INVESTING ACTIVITIES
Capital Expenditures $2.811M $2.995M
YoY Change -269.95% -144.34%
Acquisitions
YoY Change
Other Investing Activities -$1.511M $954.0K
YoY Change -107.36% -96.5%
Cash From Investing Activities -$4.322M -$2.041M
YoY Change -122.89% -109.95%
FINANCING ACTIVITIES
Cash Dividend Paid $2.067M
YoY Change -7.27%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.46M -10.76M
YoY Change -44.3% -23.6%
NET CHANGE
Cash From Operating Activities 3.318M -26.52M
Cash From Investing Activities -4.322M -2.041M
Cash From Financing Activities -12.46M -10.76M
Net Change In Cash -13.46M -39.32M
YoY Change 25.84% 65.26%
FREE CASH FLOW
Cash From Operating Activities $3.318M -$26.52M
Capital Expenditures $2.811M $2.995M
Free Cash Flow $507.0K -$29.51M
YoY Change -109.13% 25.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
40000
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000902791
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
0-21886
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
BARRETT BUSINESS SERVICES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0812977
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8100 NE Parkway Drive
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98662
CY2023Q1 dei City Area Code
CityAreaCode
360
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
828-0700
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 Per Share
CY2023Q1 dei Trading Symbol
TradingSymbol
BBSI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6806397
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52635000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91423000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
80088000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
68325000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
188013000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
163838000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20605000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19787000
CY2023Q1 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
108165000
CY2022Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
110989000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
449506000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
454362000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47272000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45954000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19273000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19804000
CY2023Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
99117000
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
104277000
CY2023Q1 us-gaap Goodwill
Goodwill
47820000
CY2022Q4 us-gaap Goodwill
Goodwill
47820000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3358000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3281000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10044000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11440000
CY2023Q1 us-gaap Assets
Assets
676390000
CY2022Q4 us-gaap Assets
Assets
686938000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5384000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8264000
CY2023Q1 bbsi Accrued Payroll Payroll Taxes And Related Benefits Liabilities Current
AccruedPayrollPayrollTaxesAndRelatedBenefitsLiabilitiesCurrent
235922000
CY2022Q4 bbsi Accrued Payroll Payroll Taxes And Related Benefits Liabilities Current
AccruedPayrollPayrollTaxesAndRelatedBenefitsLiabilitiesCurrent
222331000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
722000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
610000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7029000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6957000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29314000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31603000
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
58233000
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
62917000
CY2023Q1 bbsi Safety Incentives Liability Current
SafetyIncentivesLiabilityCurrent
1784000
CY2022Q4 bbsi Safety Incentives Liability Current
SafetyIncentivesLiabilityCurrent
2049000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
338388000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
334731000
CY2023Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
143408000
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
153070000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13559000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14225000
CY2023Q1 bbsi Customer Deposits And Other Long Term Liabilities
CustomerDepositsAndOtherLongTermLiabilities
7557000
CY2022Q4 bbsi Customer Deposits And Other Long Term Liabilities
CustomerDepositsAndOtherLongTermLiabilities
7070000
CY2023Q1 us-gaap Liabilities
Liabilities
502912000
CY2022Q4 us-gaap Liabilities
Liabilities
509096000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20500000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20500000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6800000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6800000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6871000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6871000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
68000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
69000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33559000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32744000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23942000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27594000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
163793000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
172623000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
173478000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
177842000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
676390000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
686938000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
254667000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
246375000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
213123000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
206022000
CY2023Q1 us-gaap Gross Profit
GrossProfit
41544000
CY2022Q1 us-gaap Gross Profit
GrossProfit
40353000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41226000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40165000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1677000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1508000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1359000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1320000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2315000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1638000
CY2023Q1 us-gaap Interest Expense
InterestExpense
38000
CY2022Q1 us-gaap Interest Expense
InterestExpense
34000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
36000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2313000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1636000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
954000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
316000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
135000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
819000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6866000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7406000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6985000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7474000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
819000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1397000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-5487000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3652000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14358000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4471000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14070000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
177842000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
339000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1005000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1928000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8030000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2067000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3652000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
819000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
173478000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
208530000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
411000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
185000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1830000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8575000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2229000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14358000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
185712000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
819000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1677000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1508000
CY2023Q1 bbsi Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
1756000
CY2022Q1 bbsi Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
1798000
CY2023Q1 bbsi Accretion Amortization And Gain Loss On Investments
AccretionAmortizationAndGainLossOnInvestments
-237000
CY2022Q1 bbsi Accretion Amortization And Gain Loss On Investments
AccretionAmortizationAndGainLossOnInvestments
-336000
CY2022Q1 bbsi Deferred Income Tax Expense Benefit Including Other Comprehensive Income Tax Adjustments
DeferredIncomeTaxExpenseBenefitIncludingOtherComprehensiveIncomeTaxAdjustments
25000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1928000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1830000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24175000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100589000
CY2023Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
112000
CY2022Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
223000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
818000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1633000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2880000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-153000
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
13944000
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
85897000
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2372000
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
50000
CY2023Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-14412000
CY2022Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-16894000
CY2023Q1 bbsi Increase Decrease In Safety Incentive Liability
IncreaseDecreaseInSafetyIncentiveLiability
-265000
CY2022Q1 bbsi Increase Decrease In Safety Incentive Liability
IncreaseDecreaseInSafetyIncentiveLiability
-1038000
CY2023Q1 bbsi Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
1819000
CY2022Q1 bbsi Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
1725000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
247000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
132000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26515000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30209000
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2995000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6754000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
233000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10796000
CY2023Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
1725000
CY2022Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2272000
CY2023Q1 bbsi Proceeds From Sales And Maturities Of Restricted Investments
ProceedsFromSalesAndMaturitiesOfRestrictedInvestments
2446000
CY2022Q1 bbsi Proceeds From Sales And Maturities Of Restricted Investments
ProceedsFromSalesAndMaturitiesOfRestrictedInvestments
18735000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2041000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20505000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3510000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8030000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8575000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1005000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
185000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2067000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2229000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
339000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
411000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10763000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14088000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-39319000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23792000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107378000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
78629000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68059000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54837000
CY2023Q1 bbsi Revenue Recognition Peo Service Contract Minimum Term
RevenueRecognitionPeoServiceContractMinimumTerm
P1Y
CY2023Q1 bbsi Period For Cancellation Or Termination Of Peo Service Contract
PeriodForCancellationOrTerminationOfPeoServiceContract
P30D
CY2023Q1 bbsi Payment Term For Staffing Customers
PaymentTermForStaffingCustomers
P30D
CY2023Q1 bbsi Number Of Wholly Owned Insurance Companies
NumberOfWhollyOwnedInsuranceCompanies
2
CY2022Q4 bbsi Estimate Of Liability For Unpaid Safety Incentives
EstimateOfLiabilityForUnpaidSafetyIncentives
2000000.0
CY2023Q1 bbsi Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P3M
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
885000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
893000
CY2023Q1 bbsi Estimate Of Liability For Unpaid Safety Incentives
EstimateOfLiabilityForUnpaidSafetyIncentives
1800000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
10000.00
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52635000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91423000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46074000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69405000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15424000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15955000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8763000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9224000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68059000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107378000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54837000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78629000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
10859000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
248154000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6866000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7406000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
119000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
68000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6985000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7474000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Accounting estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The preparation of our condensed consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions. These affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are used for fair value measurement of investments, allowance for doubtful accounts, deferred income taxes, carrying values for goodwill and property, equipment and software, accrued workers’ compensation liabilities and safety incentive liabilities. Actual results may or may not differ from such estimates.</span></p>
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
334478000
CY2023Q1 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-33091000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
301387000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
346087000
CY2022Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-38140000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
307947000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
12800000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
15900000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
39011000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
94851000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
106129000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1472000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
241463000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
45568000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
79860000
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
111867000
CY2022Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
215987000
CY2021Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
279407000
CY2023Q1 bbsi Workers Compensation Expense Accrual Claims For Current Period
WorkersCompensationExpenseAccrualClaimsForCurrentPeriod
4362000
CY2022Q1 bbsi Workers Compensation Expense Accrual Claims For Current Period
WorkersCompensationExpenseAccrualClaimsForCurrentPeriod
4284000
CY2023Q1 bbsi Workers Compensation Expense Adjustments Accrual Claims For Prior Periods
WorkersCompensationExpenseAdjustmentsAccrualClaimsForPriorPeriods
-1114000
CY2022Q1 bbsi Workers Compensation Expense Adjustments Accrual Claims For Prior Periods
WorkersCompensationExpenseAdjustmentsAccrualClaimsForPriorPeriods
-2919000
CY2023Q1 bbsi Workers Compensation Expense Accrual Claims
WorkersCompensationExpenseAccrualClaims
3248000
CY2022Q1 bbsi Workers Compensation Expense Accrual Claims
WorkersCompensationExpenseAccrualClaims
1365000
CY2023Q1 bbsi Workers Compensation Claim Payments Current Period
WorkersCompensationClaimPaymentsCurrentPeriod
180000
CY2022Q1 bbsi Workers Compensation Claim Payments Current Period
WorkersCompensationClaimPaymentsCurrentPeriod
225000
CY2023Q1 bbsi Claim Payments Prior Period
ClaimPaymentsPriorPeriod
17480000
CY2022Q1 bbsi Claim Payments Prior Period
ClaimPaymentsPriorPeriod
18034000
CY2023Q1 bbsi Workers Compensation Claim Payments
WorkersCompensationClaimPayments
17660000
CY2022Q1 bbsi Workers Compensation Claim Payments
WorkersCompensationClaimPayments
18259000
CY2023Q1 bbsi Workers Compensation Change In Claims Incurred In Excess Of Retention Limits
WorkersCompensationChangeInClaimsIncurredInExcessOfRetentionLimits
66000
CY2022Q1 bbsi Workers Compensation Change In Claims Incurred In Excess Of Retention Limits
WorkersCompensationChangeInClaimsIncurredInExcessOfRetentionLimits
133000
CY2023Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
201641000
CY2022Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
262646000
CY2023Q1 bbsi Workers Compensation Incurred But Not Reported
WorkersCompensationIncurredButNotReported
103804000
CY2022Q1 bbsi Workers Compensation Incurred But Not Reported
WorkersCompensationIncurredButNotReported
138604000
CY2023Q1 bbsi Workers Compensation Percent To Liabilities Incurred But Not Reported
WorkersCompensationPercentToLiabilitiesIncurredButNotReported
0.51
CY2022Q1 bbsi Workers Compensation Percent To Liabilities Incurred But Not Reported
WorkersCompensationPercentToLiabilitiesIncurredButNotReported
0.53
CY2023Q1 bbsi Description Of Renewed Agreement
DescriptionOfRenewedAgreement
The Company entered into a new arrangement for its insured program effective July 1, 2021 whereby third-party insurers assumed all risk of loss for claims incurred from July 1, 2021 to June 30, 2022 (the “2021-2022 Policy”). The 2021-2022 Policy allows for premium adjustments depending on overall policy performance. If claims develop favorably, BBSI can participate in the savings up to $20.0 million for the twelve-month policy period. If claims develop adversely, additional premium may be charged up to $7.5 million for the twelve-month policy period.
CY2023Q1 bbsi Maximum Savings Amount If Claims Develop Favorably
MaximumSavingsAmountIfClaimsDevelopFavorably
20000000.0
CY2023Q1 bbsi Maximum Additional Premium Charged Amount If Claims Develop Adversely
MaximumAdditionalPremiumChargedAmountIfClaimsDevelopAdversely
7500000
CY2020Q2 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
115700000
CY2020Q2 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
115700000
CY2023Q1 bbsi Percentage Of Claims Excluded
PercentageOfClaimsExcluded
0.10
CY2023Q1 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
178800000
CY2022Q4 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
188200000
CY2023Q1 bbsi Collateral Securities Maintain To Cover Potential Workers Compensation Claims Losses
CollateralSecuritiesMaintainToCoverPotentialWorkersCompensationClaimsLosses
53900000
CY2022Q4 bbsi Collateral Securities Maintain To Cover Potential Workers Compensation Claims Losses
CollateralSecuritiesMaintainToCoverPotentialWorkersCompensationClaimsLosses
54500000
CY2023Q1 bbsi Standby Letters Of Credit And Surety Bond
StandbyLettersOfCreditAndSuretyBond
53900000
CY2023Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
201600000
CY2022Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
216000000.0
CY2023Q1 bbsi Workers Compensation Claims Incurred In Excess Of Retention Limits
WorkersCompensationClaimsIncurredInExcessOfRetentionLimits
3000000.0
CY2022 bbsi Workers Compensation Claims Incurred In Excess Of Retention Limits
WorkersCompensationClaimsIncurredInExcessOfRetentionLimits
3000000.0
CY2023Q1 us-gaap Line Of Credit Facility Commitment Fee Description
LineOfCreditFacilityCommitmentFeeDescription
The Agreement also provides for an unused commitment fee of 0.30% per year on the average daily unused amount of the revolving credit line, as well as a fee of 1.75% of the face amount of each letter of credit reserved under the line of credit
us-gaap Income Tax Examination Penalties Expense
IncomeTaxExaminationPenaltiesExpense
1700000
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
600000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
600000
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
0

Files In Submission

Name View Source Status
0000950170-23-017333-index-headers.html Edgar Link pending
0000950170-23-017333-index.html Edgar Link pending
0000950170-23-017333.txt Edgar Link pending
0000950170-23-017333-xbrl.zip Edgar Link pending
bbsi-20230331.htm Edgar Link pending
bbsi-20230331.xsd Edgar Link pending
bbsi-ex31_1.htm Edgar Link pending
bbsi-ex31_2.htm Edgar Link pending
bbsi-ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bbsi-20230331_cal.xml Edgar Link unprocessable
bbsi-20230331_def.xml Edgar Link unprocessable
bbsi-20230331_lab.xml Edgar Link unprocessable
bbsi-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bbsi-20230331_htm.xml Edgar Link completed